Get the full picture
Sign in to uncover key details.
CANbridge Pharmaceuticals
Manufacturing · China · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Suzhou Industrial Park Building 21 Xinpi...Phone Number
+86 1084148018Website
www.canbridgepharma.comRevenue
$13.2 MillionStock Symbol
1228Industry
About CANbridge Pharmaceuticals
CANbridge is a global biopharmaceutical company founded in 2012, focused on developing and delivering innovative therapeutics for rare diseases and rare oncology. The company bridges the gap between effective therapeutic products from around the world and the rapidly expanding Chinese market. Their product portfolio includes approved therapies such as Gaurunning, Livmarli, and Hunterase, aimed at addressing unmet medical needs. CANbridge targets clients in the rare disease community, leveraging gene therapy to create impactful solutions for patients with rare genetic conditions.Explore more
CANbridge Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to CANbridge Pharmaceuticals
Compare insights from companies similar to CANbridge Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
CANbridge Pharmaceuticals Tech Stack
A closer look at the technologies used by CANbridge Pharmaceuticals
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CANbridge Pharmaceuticals
Sign Up For FreeTo access detailed company insights
CANbridge is a global biopharmaceutical company founded in 2012, focused on developing and delivering innovative therapeutics for rare diseases and rare oncology. The company bridges the gap between effective therapeutic products from around the world and the rapidly expanding Chinese market. Their product portfolio includes approved therapies such... Read More
